Drug Discovery Solutions
-
Cell Line Development Solutions
5/15/2023
Discover technology that enables a cost-effective, easily implemented cell line development workflow while delivering high productivity pools and cell lines.
-
Container Closure Integrity Testing
Lonza’s Drug Product Services delivers a holistic approach to DP development that prevents problems early and produces a product that is fit for purpose.
-
A Fully Integrated Toolbox For Therapeutic Protein Expression
The GS Xceed® Gene Expression System is a comprehensive toolbox for development of biologics that has been used to develop not only monoclonal antibodies but also a wide variety of new molecular formats.
-
DNA2.0 - Gene Optimization And Synthesis
2/13/2024
ATUM is building on DNA2.0's reputation for rapid, reliable and accurate DNA synthesis. Using our proprietary GeneGPS® and VectorGPS® platforms we design constructs optimized to express in your system, whether that's a single gene in E. coli, a metabolic pathway in yeast or a complex bispecific antibody in mammalian cells.
-
NanoAssemblrĀ® Sparkā¢: Freedom To Discover
4/14/2022
The NanoAssemblr® Spark™ is ideal for nanomedicine formulation discovery and screening at microliter scales.
-
Integrated Biotech Services: From Strain To Commercial Product
Backed by Lonza’s more than 30 years’ experience and expertise in biological processing and our track record in the chemical and biotechnological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.
-
Surfactant Analysis Services
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.
-
Bioengineering Solutions Using A Fully Integrated Ecosystem
5/30/2023
Find solutions to meet your gene, protein, antibody, or cell line needs using two gene synthesis platforms that enable the design of constructs optimized for maximal expression/yield in your system.
-
ADCs: From Design To Development
1/4/2024
Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.
-
Drug Substance Synthesis And Manufacturing
3/3/2022
We take an agile and flexible approach with our customers programs, offering bespoke drug substance synthesis and manufacturing, helping to accelerate molecules from candidate selection to clinical proof-of-concept and onwards towards commercial scale.